Skip to main content
SpringerLink
Log in

Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China

  • Original Article
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective

Hepatocellular carcinoma (HCC) is a complex disease which associates with both environmental and genetic factors. The purpose of this study was to investigate whether the genetic polymorphisms of UDP-glucuronosyltransferase (UGT1A7), an important phase II biotransformation enzyme, and X-ray repair cross-complementing group 1(XRCC1), a pivotal DNA-repair gene, were related to the risk of HCC in Northeast China.

Methods

One hundred and thirty six HCC patients and one hundred and thirty six frequency-matched controls were included in this hospital-based case-control study. Genotypes of UGT1A7 and XRCC1 were determined using allele-specific polymerase chain reaction (AS-PCR) and PCR-restriction fragment length polymorphism (RFLP), and for which the odds ratio (OR) with 95% confidence interval (95% CI) were calculated.

Results

The proportion of UGT1A7 low enzymatic allele (*2 or *3) was higher in HCC patients than those in controls. The UGT1A7*1/*2 and *3/*3 genotypes were associated with higher HCC risk (OR=2.09, 95%CI: 1.10–3.97; OR=5.67, 95%CI: 1.76–18.30, respectively). The XRCC1 codon 399 Arg/Gln genotype could also elevate HCC risk (OR=2.16, 95% CI 1.29–3.61). In addition to polymorphisms of UGT1A7 and XRCC1, multivariate logistic regression analysis demonstrated that other significant independent factors associated with HCC were HBV infection (OR=68.07, 95%CI: 28.03–165.26), HCV infection (OR=30.97, 95%CI: 8.06–118.94) and family history of HCC (OR=10.62, 95%CI: 2.22–50.77).

Conclusion

The study shows that the polymorphisms of UGT1A7 and XRCC1 are associated with HCC risk. Determination of the polymorphisms of UGT1A7 and XRCC1 may provide an important clue to preventive measure against HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, and Pisani P. Global Cancer Statistics, 2002[J]. CA Cancer J Clin 2005; 55: 74–108.

    Article  PubMed  Google Scholar 

  2. Cai L, Binh G, Parkin D, et al. Cancer trends in Asian Pacific rim region[J]. Tumor (in Chinese) 2004; 24: 422–426.

    Google Scholar 

  3. Jing LB, Yu GH, Guo CS, et al. An analysis of cancer incidence and mortality in some cities,Liaoning province[J]. Bulletin of Chinese Cancer (in Chinese) 2003; 12: 393–394.

    Google Scholar 

  4. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment[J]. Nat Rev Cancer 2006; 6: 674–687.

    Article  CAS  PubMed  Google Scholar 

  5. Radominska-Pandya A, Czernik PJ, Little JM, et al. Structural and functional studies of UDPglucuronosyltransferases[J]. Drug Metab Rev 1999; 31: 817–899.

    Article  CAS  PubMed  Google Scholar 

  6. Tukey RH, Strassburg CP. Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease[J]. Annu Rev Pharmacol Toxicol 2000; 40: 581–616.

    Article  CAS  PubMed  Google Scholar 

  7. Guillemette C, Ritter JK, Auyeung DJ, et al. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene[J]. Pharmacogenetics 2000; 10: 629–644.

    Article  CAS  PubMed  Google Scholar 

  8. Verlaan M, Drenth JP, Truninger K, et al. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases[J]. J Med Genet 2005; 42: e62.

    Article  CAS  PubMed  Google Scholar 

  9. Vogel A, Kneip S, Barut A, et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene[J]. Gastroenterology 2001; 121: 1136–1144.

    Article  CAS  PubMed  Google Scholar 

  10. Wang Y, Kato N, Hoshida Y, et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in japanese patients with hepatitis C virus infection[J]. Clin Cancer Res 2004; 10: 2441–2446.

    Article  CAS  PubMed  Google Scholar 

  11. Tseng CS, Tang KS, Lo HW, et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age[J]. Am J Gastroenterol 2005; 100: 1758–1763.

    Article  CAS  PubMed  Google Scholar 

  12. Stücker I, Loriot MA, N’Koutchou G, et al. UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers?[J]. BMC Cancer 2007; 7: 214.

    Article  PubMed  Google Scholar 

  13. Borentain P, Gérolami V, Ananian P, et al. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian livertransplanted patients[J]. Eur J Cancer 2007; 43: 2479–2486.

    Article  CAS  PubMed  Google Scholar 

  14. Horton JK, Watson M, Stefanick DF, et al. XRCC1 and DNA polymerase [beta] in cellular protection against cytotoxic DNA single-strand breaks[J]. Cell Res 2008; 18: 48–63.

    Article  CAS  PubMed  Google Scholar 

  15. Yu Z, Chen J, Ford BN, et al. Human DNA repair systems: an overview[J]. Environ Mol Mutagen 1999; 33: 3–20.

    Article  CAS  PubMed  Google Scholar 

  16. Petermann E, Keil C, Shiao LO. Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER[J]. DNA Repair 2006; 5: 544–555.

    Article  CAS  PubMed  Google Scholar 

  17. Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects[J]. Carcinogenesis 2001; 22: 1437–1445.

    Article  CAS  PubMed  Google Scholar 

  18. Villeneuve L, Girard H, Fortier LC, et al. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs[J]. J Pharmacol Exp Ther 2003; 307: 117–128.

    Article  CAS  PubMed  Google Scholar 

  19. Ando M, Ando Y, Sekido Y, et al. Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients[J]. Jpn J Cancer Res 2002; 93: 591–597.

    CAS  PubMed  Google Scholar 

  20. Chen K, Jin M, Zhu Y, et al. Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population[J]. J Gastroenterol Hepatol 2006; 21: 1036–1041.

    Article  CAS  PubMed  Google Scholar 

  21. Strassburg CP, Vogel A, Kneip S, et al. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer[J]. Gut 2002; 50: 851–856.

    Article  CAS  PubMed  Google Scholar 

  22. Butler LM, Duguay Y, Millikan RC, et al. Joint effects between UDP-glucuronosyltransferase 1A7 genotype and dietary carcinogen exposure on risk of colon cancer[J]. Cancer Epidemiol Biomarkers Prev 2005; 14: 1626–1632.

    Article  CAS  PubMed  Google Scholar 

  23. van der Logt EM, Bergevoet SM, Roelofs HM, et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk[J]. Carcinogenesis 2004; 25: 2407–2415.

    Article  PubMed  Google Scholar 

  24. Araki J, Kobayashi Y, Iwasa M, et al. Polymorphism of UDP-glucuronosyltransferase 1A7 gene: A possible new risk factor for lung cancer[J]. Eur J Cancer. 2005; 41: 2360–2365.

    Article  CAS  PubMed  Google Scholar 

  25. Feng FY, Liang G, Lu WF, et al. Correlation of polymorphisms of UDP-glucuronosyltransferase 1A7 gene to genetic susceptibility of lung cancer[J]. Chin J Cancer(in Chinese) 2005; 24: 1085–1090.

    CAS  Google Scholar 

  26. Ralph DA, Zhao LP, Aston CE, et al. Age-specific association of steroid hormone pathway gene polymorphisms with breast cancer risk[J]. Cancer 2007; 109: 1940–1948.

    Article  CAS  PubMed  Google Scholar 

  27. Ockenga J, Vogel A, Teich N, et al. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer[J]. Gastroenterology 2003; 124: 1802–1808.

    Article  CAS  PubMed  Google Scholar 

  28. Kong SY, Ki CS, Yoo BC, et al. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers[J]. Cancer Sci 2008; 99: 340–344.

    Article  CAS  PubMed  Google Scholar 

  29. Lao T, Gu W, and Huang Q. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk[J]. Mutagenesis 2008; 23: 523–532.

    Article  CAS  PubMed  Google Scholar 

  30. Li M, Yin Z, Guan P, et al. XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers[J]. Lung Cancer 2008; 62: 145–151.

    Article  PubMed  Google Scholar 

  31. Stern MC, Conti DV, Siegmund KD, et al. DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese health study[J]. Cancer Epidemiol Biomarkers Prev 2007; 16: 2363–2372.

    Article  CAS  PubMed  Google Scholar 

  32. Ratnasinghe LD, Abnet C, Qiao Y-L, et al. Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer[J]. Cancer Lett 2004; 216: 157–164.

    Article  CAS  PubMed  Google Scholar 

  33. Yu MW, Yang SY, Pan IJ, et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma[J]. J Natl Cancer Inst 2003; 95: 1485–1488.

    CAS  PubMed  Google Scholar 

  34. Kirk GD, Turner PC, Gong Y, et al. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity[J]. Cancer Epidemiol Biomarkers Prev 2005; 14: 373–379.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology and Key Laboratory of Cancer Etiology and Intervention of Liaoning Province, School of Public Health, China Medical University, Shenyang, 110001, China

    Zhi-fang Jia, Xue-lian Li, Xin Xu, Zhi-hua Yin, Peng Guan & Bao-sen Zhou

  2. Department of Intervention, the First Affiliated Hospital, China Medical University, Shenyang, 110001, China

    Hong-ying Su

Authors
  1. Zhi-fang Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hong-ying Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xue-lian Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xin Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhi-hua Yin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peng Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bao-sen Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bao-sen Zhou.

Additional information

This work was supported by the grant from Department of Education of Liaoning Province, China (No. 2008S232)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jia, Zf., Su, Hy., Li, Xl. et al. Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China. Chin. J. Cancer Res. 22, 260–266 (2010). https://doi.org/10.1007/s11670-010-0260-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-010-0260-z

CLC number

Key words

Search

Navigation